“Raloxifene”的搜索结果，显示 81-90 项，共有 6529 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The primary aim of this study is to evaluate the distribution of marker levels determined by this multi-marker, multi-compartment blood DNA ...

4. Metastatic castration-resistant prostate cancer (mCRPC)

   To know whether the cancer is metastatic castration-resistant prostate cancer (mCRPC), healthcare professionals use imaging tests to look for signs that the ...

5. 血液科- 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

7. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

8. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and ...

9. Mayo Clinic Obstetrics and Gynecology Physician Update - November 2024

   Page 1.

10. 血液科- 临床试验- 妙佑医疗国际

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...